| AXGN | | Axogen, Inc. | Erick Wayne Devinney | Chief Innovation Officer | Mar 16, 2025 | Option/RSU Exercise | - | 32,462 | - | 232,873 | Mar 19, 2025, 05:24 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | Chief Innovation Officer | Mar 19, 2025 | Sale | $17.50 | 15,111 | 264,443 | 217,762 | Mar 19, 2025, 05:24 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | Chief Innovation Officer | Mar 04, 2025 | Tax Payment (Shares) | $18.35 | 8,296 | 152,232 | 201,005 | Mar 04, 2025, 07:22 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | Chief Innovation Officer | Feb 28, 2025 | Option/RSU Exercise | - | 24,799 | - | 209,301 | Mar 04, 2025, 07:22 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | Chief Innovation Officer | Feb 25, 2025 | Tax Payment (Shares) | $16.50 | 972 | 16,038 | 184,502 | Feb 26, 2025, 04:23 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | Chief Innovation Officer | Mar 16, 2024 | Option/RSU Exercise | - | 18,675 | - | 180,615 | Mar 25, 2024, 09:40 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | Chief Innovation Officer | Mar 21, 2024 | Sale | $7.68 | 4,578 | 35,159 | 177,474 | Mar 25, 2024, 09:40 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Oct 13, 2023 | Disposition to Issuer | $4.04 | 864 | 3,491 | 113,377 | Oct 13, 2023, 08:29 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Mar 16, 2023 | Option/RSU Exercise | - | 8,900 | - | 113,596 | Mar 20, 2023, 09:08 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Mar 16, 2023 | Tax Payment (Shares) | $8.27 | 2,769 | 22,900 | 112,662 | Mar 20, 2023, 09:08 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Dec 27, 2022 | Tax Payment (Shares) | $9.44 | 187 | 1,765 | 106,531 | Dec 29, 2022, 08:56 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Dec 27, 2022 | Option/RSU Exercise | - | 750 | - | 106,718 | Dec 29, 2022, 08:56 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Dec 27, 2022 | Tax Payment (Shares) | $9.44 | 10,784 | 101,801 | 105,968 | Dec 28, 2022, 09:34 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Dec 27, 2022 | Option/RSU Exercise | $5.09 | 20,000 | 101,800 | 116,752 | Dec 28, 2022, 09:34 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Jul 19, 2022 | Disposition to Issuer | $8.40 | 405 | 3,402 | 96,752 | Jul 20, 2022, 04:01 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Mar 16, 2022 | Tax Payment (Shares) | $7.97 | 1,497 | 11,931 | 92,578 | Mar 18, 2022, 04:03 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Mar 16, 2022 | Option/RSU Exercise | - | 6,000 | - | 94,075 | Mar 18, 2022, 04:03 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Feb 15, 2022 | Tax Payment (Shares) | $8.42 | 357 | 3,006 | 88,075 | Feb 17, 2022, 04:05 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Dec 27, 2021 | Option/RSU Exercise | - | 750 | - | 87,436 | Dec 29, 2021, 04:17 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Dec 27, 2021 | Tax Payment (Shares) | $9.74 | 187 | 1,821 | 87,249 | Dec 29, 2021, 04:17 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Dec 20, 2021 | Tax Payment (Shares) | $9.24 | 144 | 1,331 | 86,686 | Dec 22, 2021, 04:03 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Dec 20, 2021 | Option/RSU Exercise | - | 575 | - | 86,830 | Dec 22, 2021, 04:03 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Dec 15, 2021 | Tax Payment (Shares) | $8.80 | 4,171 | 36,705 | 86,255 | Dec 17, 2021, 04:02 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Dec 15, 2021 | Option/RSU Exercise | $3.67 | 10,000 | 36,700 | 90,426 | Dec 17, 2021, 04:02 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP Peripheral Nerve Science | Jul 20, 2021 | Tax Payment (Shares) | $19.20 | 392 | 7,526 | 80,426 | Jul 21, 2021, 04:16 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP of Clin. & Trans. Sciences | Apr 28, 2021 | Option/RSU Exercise | $2.86 | 10,000 | 28,600 | 78,082 | Apr 30, 2021, 04:10 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP, Clinical&Translational Sc | Feb 17, 2021 | Tax Payment (Shares) | $18.70 | 1,864 | 34,857 | 68,082 | Feb 18, 2021, 05:26 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP, Clinical&Translational Sc | Dec 29, 2020 | Sale | $17.81 | 371 | 6,608 | 63,240 | Dec 30, 2020, 05:33 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP, Clinical&Translational Sc | Dec 21, 2020 | Sale | $16.42 | 147 | 2,414 | 62,111 | Dec 22, 2020, 03:22 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP, Clinical&Translational Sc | Dec 15, 2020 | Option/RSU Exercise | $4.81 | 15,000 | 72,150 | 66,056 | Dec 17, 2020, 04:41 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP, Clinical&Translational Sc | Dec 15, 2020 | Tax Payment (Shares) | $16.50 | 4,373 | 72,155 | 61,683 | Dec 17, 2020, 04:41 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP, Clinical&Translational Sc | Apr 28, 2020 | Option/RSU Exercise | $0.27 | 2,530 | 683 | 51,056 | Apr 29, 2020, 05:56 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP, Clinical&Translational Sc | Feb 18, 2020 | Tax Payment (Shares) | $14.68 | 1,849 | 27,143 | 48,526 | Feb 20, 2020, 01:19 PM |
| AXGN | | Axogen, Inc. | Erick Wayne Devinney | VP, Clinical&Translational Sc | Dec 18, 2019 | Tax Payment (Shares) | $16.73 | 281 | 4,701 | 42,840 | Dec 20, 2019, 04:27 PM |
| AXGN | | AxoGen, Inc. | Erick Wayne Devinney | VP, Clinical&Translational Sc | Feb 15, 2019 | Tax Payment (Shares) | $17.57 | 1,498 | 26,320 | 41,971 | Feb 19, 2019, 01:24 PM |
| AXGN | | AxoGen, Inc. | Erick Wayne Devinney | VP, Clinical&Translational Sc | Nov 13, 2018 | Tax Payment (Shares) | $33.28 | 2,882 | 95,913 | 37,136 | Nov 15, 2018, 05:18 PM |
| AXGN | | AxoGen, Inc. | Erick Wayne Devinney | VP, Clinical&Translational Sc | Nov 13, 2018 | Option/RSU Exercise | $2.72 | 35,274 | 95,974 | 40,018 | Nov 15, 2018, 05:18 PM |
| AXGN | | AxoGen, Inc. | Erick Wayne Devinney | VP, Clinical&Translational Sc | Mar 14, 2017 | Option/RSU Exercise | $0.27 | 5,018 | 1,355 | 5,018 | Mar 14, 2017, 07:32 PM |
